Skip to main content

Table 3 Psychometric Analysis

From: Development and validation of a psoriasis treatment acceptability measure through group concept mapping

Comparisons from the TAQ with Strong Correlations (≥ 0.80)

Inter-item Correlations

Item 2: Be effective in treating psoriasis for skin and other areas

Item 3: Be safe for long-term use

0.805

Item 2: Be effective in treating psoriasis for skin and other areas

Item 4: Not lose effectiveness over time

0.802

Item 3: Be safe for long term use

Item 4: Not lose effectiveness over time

0.823

Item 3: Be safe for long term use

Item 10: Relieve the itching

0.842

Item 6: Be easy to include in your (a patient’s) normal routine

Item 7: Be simple and quick to administer

0.851

Analysis of Known-Groups Validity

Known-Group

TAQ Total Mean (SD) Score

(n = 197)

P-value

DLQI

No or small effect on patient’s life

44.3 (12.73)

0.0072

Moderate effect on patient’s life

46.3 (8.38)

Very large effect on patient’s life

49.2 (7.63)

Extremely large effect on patient’s life

52.6 (6.38)

CGI-S

Mild

47.2 (10.65)

0.8106

Moderate

46.8 (9.12)

Severe

47.8 (8.85)

  1. CGI-S - Clinician Global Impression – Severity; DLQI - Dermatology Life Quality Index; SD - standard deviation; TAQ - Treatment Acceptability Questionnaire